The paper introduces PhenoProfiler, a sophisticated deep learning framework designed to revolutionize image-based drug discovery by analyzing how cells respond to chemical treatments. Unlike traditional methods that require complex preprocessing and image segmentation, this end-to-end system directly converts high-content microscopy images into compact, biologically meaningful representations. The model utilizes a unique multi-objective learning strategy—combining classification, regression, and contrastive learning—to ensure high accuracy and robustness against technical noise. Extensive testing on hundreds of thousands of images proves that PhenoProfiler significantly outperforms existing tools in identifying drug mechanisms and generalizing across different cell lines. Furthermore, its specialized phenotype correction strategy enhances the detection of subtle biological signals, making it a scalable solution for AI-driven pharmaceutical research. This innovation facilitates a more precise, interpretable understanding of cellular behavior to accelerate the identification of new therapeutic targets.
References:
- Li B, Zhang B, Zhang C, et al. PhenoProfiler: advancing phenotypic learning for image-based drug discovery[J]. Nature Communications, 2025.
